The use of Low Dose Naltrexone and Cannabinoids to treat cancer

Low Dose Naltrexone (LDN), a unique anti-inflammatory and immune stimulant, greatly enhances responses to other cancer treatments and immunotherapies. We have shown that CBD and LDN together greatly enhance the susceptibility of tumour cells in the laboratory to be killed by chemotherapy. The effect is so great that we can get the same kill with half the dose of chemotherapy.